Wolfgang Rist

Birkendorfer Str. 65
Biberach An Der Riss, BW 88400, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Injected Eye, Fellow Eye and Systemic Pharmacokinetic Modeling of Intravitreally Administered Bevacizumab.

Injected Eye, Fellow Eye and Systemic Pharmacokinetic Modeling of Intravitreally Administered Bevacizumab.

Journal: Molecular pharmaceutics

Published: April 02, 2026

Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue.

Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue.

Journal: Journal of medicinal chemistry

Published: November 11, 2025

Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling.

Glucagon controls obesity-specific energy expenditure via persistent cAMP/PKA signaling.

Journal: Journal of hepatology

Published: February 20, 2025

The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.

The dual GCGR/GLP-1R agonist survodutide: Biomarkers and pharmacological profiling for clinical candidate selection.

Journal: Diabetes, obesity & metabolism

Published: January 24, 2024

Transcriptomic and Proteomic Changes Driving Pulmonary Fibrosis Resolution in Young and Old Mice.

Transcriptomic and Proteomic Changes Driving Pulmonary Fibrosis Resolution in Young and Old Mice.

Journal: American journal of respiratory cell and molecular biology

Published: July 06, 2023

Transcriptomic and proteomic profiling of young and old mice in the bleomycin model reveals high similarity.

Transcriptomic and proteomic profiling of young and old mice in the bleomycin model reveals high similarity.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: January 10, 2023

BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy.

BI 456906: Discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy.

Journal: Molecular metabolism

Published: August 26, 2022

Characterization of a flexible AAV-DTR/DT mouse model of acute epithelial lung injury.

Characterization of a flexible AAV-DTR/DT mouse model of acute epithelial lung injury.

Journal: American journal of physiology. Lung cellular and molecular physiology

Published: June 28, 2022

Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96.

Evaluating Antibody Pharmacokinetics as Prerequisite for Determining True Efficacy as Shown by Dual Targeting of PD-1 and CD96.

Journal: Biomedicines

Published: June 10, 2022

Whole lung proteome of an acute epithelial injury mouse model in comparison to spatially resolved proteomes.

Whole lung proteome of an acute epithelial injury mouse model in comparison to spatially resolved proteomes.

Journal: Proteomics

Published: December 17, 2021

Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice.

Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice.

Journal: Disease models & mechanisms

Published: May 07, 2021

The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice.

The calcitonin receptor is the main mediator of LAAMA's body weight lowering effects in male mice.

Journal: European journal of pharmacology

Published: April 26, 2021

Showing 1-12 of 17

Last Updated: 09/26/2026